Skip to main content
. 2021 Jul 1;195(2):186–193. doi: 10.1111/bjh.17608

Table II.

Rate of serological response to BNT162b2 vaccine.

Cohort Antibody response n (%) P value vs. healthy controls
Positive Negative
Healthy controls 63 (98) 1 (2)
All myeloma 133 (78) 38 (22) 0·000132
Active myeloma* 121 (76) 38 (24) 0·00062
Smoldering myeloma* 12 (100) 0 (0) 0·722
*

Active myeloma versus smouldering myeloma: P = 0·044.